These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Carbidopa-based modulation of the functional effect of the AAV2-hAADC gene therapy in 6-OHDA lesioned rats. Ciesielska A, Sharma N, Beyer J, Forsayeth J, Bankiewicz K. PLoS One; 2015 Dec 01; 10(4):e0122708. PubMed ID: 25860990 [Abstract] [Full Text] [Related]
8. Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease. Shen Y, Muramatsu SI, Ikeguchi K, Fujimoto KI, Fan DS, Ogawa M, Mizukami H, Urabe M, Kume A, Nagatsu I, Urano F, Suzuki T, Ichinose H, Nagatsu T, Monahan J, Nakano I, Ozawa K. Hum Gene Ther; 2000 Jul 20; 11(11):1509-19. PubMed ID: 10945765 [Abstract] [Full Text] [Related]
17. A pathogenic S250F missense mutation results in a mouse model of mild aromatic l-amino acid decarboxylase (AADC) deficiency. Caine C, Shohat M, Kim JK, Nakanishi K, Homma S, Mosharov EV, Monani UR. Hum Mol Genet; 2017 Nov 15; 26(22):4406-4415. PubMed ID: 28973165 [Abstract] [Full Text] [Related]
18. Intraparenchymal delivery of adeno-associated virus vectors for the gene therapy of neurological diseases. Kumagai S, Nakajima T, Muramatsu SI. Expert Opin Biol Ther; 2024 Aug 15; 24(8):773-785. PubMed ID: 39066718 [Abstract] [Full Text] [Related]
19. Adeno-associated virus vector-mediated triple gene transfer of dopamine synthetic enzymes. Fan D, Shen Y, Kang D, Nakano I, Ozawa K. Chin Med J (Engl); 2001 Dec 15; 114(12):1276-9. PubMed ID: 11793852 [Abstract] [Full Text] [Related]
20. Case report: discovery of 2 gene variants for aromatic L-amino acid decarboxylase deficiency in 2 African American siblings. Monteleone B, Hyland K. BMC Neurol; 2020 Jan 09; 20(1):12. PubMed ID: 31918669 [Abstract] [Full Text] [Related] Page: [Next] [New Search]